Company intelligence / Profile preview

Rousselot

Chicago, Illinois, United Statesrousselot.com ↗

Ownership: Private
Employees: ~712
Development stage: Commercial

Overview

Rousselot’s collagen peptide products—especially the flagship brand Peptan®—have demonstrated efficacy in multiple double-blind placebo-controlled clinical studies for improving skin hydration, elasticity and density while reducing wrinkles. Their ingredients are widely used globally in supplements targeting beauty-from-within and joint health markets. They also supply pharmaceutical-grade gelatins as excipients for capsule production and offer specialized biomaterials to the biomedical sector.

Therapeutic areas: OtherDermatologyRheumatology
Modalities: Collagen peptidesGelatinBiomaterials
Industry: Food & Nutrition

Drug pipeline

2 assets

StabiCaps

Commercial

Indications: Drug delivery

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Rousselot.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rousselot.

Explore the full profile